Related Stories

How to Prescribe Controlled Substances Under COVID-19 Waivers - 03/25/2020

If you treat patients with chronic pain, you can temporarily prescribe certain controlled substances during a telemedicine visit under state and federal waivers issued in response to the COVID-19 pandemic.

Alcohol-Related Deaths Rising Nationwide - 02/06/2020

More than 1 million people died from alcohol-related causes over the past 20 years, a new study shows. The study, in which researchers analyzed all U.S. death certificates from 1999 to 2017, found that the number of alcohol-related deaths more than doubled during that time: from 35,914 to 72,558.

Your Video Guide to Texas' New Prescription Drug Monitoring Program - 02/05/2020

In an effort to address the very real and debilitating crisis caused by the misuse of  pain medicines, the Texas Legislature has passed legislation to mandate that all prescribers and pharmacists check the state's Prescription Drug Monitoring Program (PDMP) before prescribing or dispensing certain medications.

No Cannabis for Pregnant Women or New Mothers, FDA Warns - 10/22/2019

Texas physicians are encouraged to help the U.S. Food and Drug Administration spread the word to pregnant and breast-feeding mothers to avoid using cannabis and cannabis-derived products.

Help Promote National Drug Prescription Take Back Day on Oct. 26 - 10/22/2019

Prescription Drug Take Back Day, which allows people to dispose of prescription drugs safely and anonymously, is scheduled for Oct. 26 at locations throughout the state.

“The future” of pain treatment? - 08/15/2019

Some physicians, depending on the situation, are avoiding opioids to every reasonable degree, doing their part to keep patients off the drugs that killed more than 42,000 people in the United States in 2016. Fort Worth anesthesiologist Aaron Shiraz, MD, and his group, Trinity Medical Associates, are taking it to a rarely seen extreme.

Get Qualified to Prescribe Opioid Addiction Medication - 07/22/2019

If you care for patients with opioid-use disorder, you’re probably familiar with buprenorphine, a medication that can be used at home to treat opioid addiction. But if you haven’t heard about it, or if you would like more information, tune in to a free online training course to qualify for a waiver to prescribe buprenorphine.

Changing the Conversation about Addiction - 05/24/2019

Drug addiction is a chronic medical disease, and stigma about it is keeping millions of Americans – including the growing number who suffer with opioid addiction – from getting proper medical treatment, one of the nation’s foremost addiction specialists told the closing general session audience at TexMed 2019 in Dallas.

Addiction Treatment Helps More Than Incarceration - 04/23/2019

We appreciate the opportunity to voice support and offer additional suggestions for Senate Bill 1147, which allows a judge to require that a defendant undergo an evaluation as to whether they would benefit from medication-assisted treatment (MAT) for alcohol dependence as a condition of their community supervision.

Improve Access to MAT for Medicaid Patients - 04/09/2019

While many patients want treatment for their substance use disorder (SUD), they often lack access to the most effective treatment for their individual needs. With proper treatment and support, people with SUD can recover and live, work, and contribute to the community. SUD can be successfully managed, generally with a combination of several evidence-based practices such as medication-assisted treatment (MAT), individual or group counseling, and inpatient residential treatment.

Texas Physicians Release 2019 Legislative Prescription for a Healthier Texas - 01/03/2019

The political landscape has changed, but many of the health care issues hotly debated two years ago are back on the table for the upcoming 86th session of the Texas Legislature. The Texas Medical Association’s (TMA’s) goal: persuade legislators to improve Texas laws for patients and their physicians.

New Prescription Forms Taking Months to Deliver - 12/20/2018

If you haven’t already ordered new prescription forms for certain controlled substances, you should do so soon in order to stay compliant with new state regulations that will take effect next year. Because of the volume of orders, the new forms are currently taking about two months to be delivered.

FDA Approves Cannabidiol, But Drug Still Faces Hurdles - 07/02/2018

The U.S. Food and Drug Administration this week approved the first medication derived from marijuana, which could be used to treat two rare forms of childhood epilepsy.

U.S. Opioid Abuse: Teaching Is Fundamental - 05/03/2018

Abuse of prescription pain medications has become a national epidemic behind the top three most commonly abused substances ― alcohol, tobacco, and marijuana ― according to the U.S. Department of Health and Human Services and the U.S. Centers for Disease Control and Prevention.

Surgeon General Wants Naloxone to Save More Lives - 04/16/2018

The U.S. Surgeon General last week issued an advisory stressing that the opioid antagonist naloxone saves lives of people at risk of overdose.

San Antonio Snuffs Out Tobacco Sales to Teens - 01/30/2018

A bill to raise the state’s age to purchase tobacco to 21 burned out during last year’s legislative session. But now that the city of San Antonio has done it on a local level, advocates of “T-21” are hoping to light a fire under other Texas cities ― and state lawmakers ― to do the same.

Physicians Will Lead Legislature’s Controlled Substances Committee - 01/18/2018

When a special joint committee of the Texas Legislature tackles issues with controlled substances this year, physician-lawmakers will take the lead.

FDA Says No to Prescription Opioid Cough Meds for Children - 01/17/2018

FDA officials announced recently that prescription cough and cold medications that contain codeine or hydrocodone should not be given to patients younger than 18 years because the medicines’ risks outweigh their benefits in children.

Learn How to Curb Youth Substance Abuse - 01/05/2018

Learn how to integrate substance use screening and intervention into your practice, or to manage adolescent patients who use substances or are in recovery, with a new continuing medical education   module from the Texas Department of State Health Services (DSHS).

Town Hall Meetings to Discuss Prescription Drug Abuse - 07/17/2017

The Texas Health and Human Services Commission is conducting a series of regional town-hall meetings to discuss best practices and solutions to prevent prescription drug misuse statewide.

Marijuana as Treatment Lacks Sufficient Scientific Study, but Preserve Patient-Physician Dialogue - 07/06/2017

In 2015, TMA completed a systemic review of the research and clinical indications of marijuana, its compounds, and its potential risks and therapeutic benefits. Having reviewed more than two decades of studies, we confidently join other medical associations in recognizing there is a lack of science and practice on the medical effects of marijuana to inform physicians adequately about its proper application and use for various health conditions. Unfortunately, the lack of expanded study and evidence on marijuana as medicine is because of its Schedule 1 classification, which has greatly limited the types and rigor of research. We have endorsed a rescheduling of marijuana to facilitate research — including cannabinoid-based medications, as well as the most appropriate delivery methods.

Feds Give Texas Millions to Fight Opioid Addiction - 06/04/2017

Texas is set to receive an injection of federal dollars as part of a nationwide effort to fight opioid addiction.

Reminder: Physicians No Longer Need Controlled Substances Registration - 05/15/2017

TMA reminds its members they no longer need a Department of Public Safety controlled substances registration.

Training to Focus on Opioid Prescribing Guidelines - 04/28/2017

The U.S. Centers for Disease Control and Prevention (CDC) has launched an online training series to help clinicians apply its opioid prescribing guidelines for adults with chronic pain.

DEA Investigations - 04/26/2017

This article provides general information regarding what to do, and what not to do, when a U.S. Drug Enforcement Administration (DEA) investigator contacts you.